The BSE Sensex logged its sixth fall in seven days by slipping 143 points to 24,682.03 ahead of key macroeconomic data and quarterly numbers of IT major TCS. The NSE Nifty index after cracking 7,500-mark, touched the session’s low of 7,487.80. However, fag-end buying helped the gauge to recover part of the lost ground to settle 53.55 points or 0.71 per cent down at 7,510.30.
Below are the top 11 stocks that made news today
Tata Consultancy Services: Shares of the IT major slumped to its 52-week low level and closed 1.65 per cent down at Rs 2324.05 ahead of its third quarter earnings announcement.
Federal Bank: Shares of the bank settled 7.74 per cent down at Rs 48.25 after the bank registered 38.5 per cent year-on-year fall in its net profit for the quarter ended December 2015. The bank posted a net profit of Rs 162.72 crore for the quarter ended December 2015 as compared to Rs 264.69 crore in the corresponding quarter a year ago.
Omax Auto: Shares of the company gained as much as 13.54 per cent intraday on Tuesday after the auto component maker informed BSE on Monday post market hours that it has sold the remaining 51 per cent stake in its subsidiary GMAX Auto. The share price of the company later settled 4.13 per cent up at Rs 85.75.
IndusInd Bank: Shares of the private sector lender closed 2.68 per cent down at Rs 85.75 despite it posting a 30 per cent increase in net profit to Rs 581.02 crore for the third quarter ended December 31, 2015-16. The shares fell after the bank increased its provisions by 80 per cent to Rs 177.08 crore for the quarter ended December 2015 from Rs 98 crore in the same quarter last year.
Vivimed Labs: Shares of the company were trading 1.30 per cent up at Rs 475.00 (9.33 am) after the company on Monday informed BSE that the Board of Directors at its meeting held on January 11, 2016 has approved the sub division proposal of company’s equity shares from the existing face value of Rs 10 per equity share to Rs 2 per equity share subject to the approval of company’s shareholders, which is proposed to be obtained through Postal Ballot & E-Voting. Later, share price of the comapny closed 1.26 per cent down at Rs 463.
PI Industries: Shares of the company settled 2.21 per cent up at Rs 710.10 after the company informed BSE that it has commenced the commercial production at its third unit located at Sterling SEZ facility, Jambusar in Gujarat with effect from January 11, 2016.
Unitech Ltd: Shares of the company were trading 4.67 per cent down at Rs 6.33 (9.37 am) after a Delhi court on Monday sent Unitech Ltd chairman and its two managing directors to 14-day judicial custody in alleged cheating cases filed by two investors.
Larsen and Toubro: Shares of the company were trading 1.63 per cent up at Rs 1193.95 (9.40 am) after Credit Suisse upgraded the stocks to “outperform” from “neutral” citing sustainable expectations, potential for positive surprise and reasonable valuations. Later, the shares of the company ended 0.41 per cent up at Rs 1179.60.
National Building Construction Corporation (NBCC): Shares of the company were trading 1.91 per cent up at Rs 1008.15 (9.45 am). In a bid to redevelop two stations – Gomtinagar in Lucknow and Bhubaneswar in Odisha, Indian Railways is reportedly in discussion with NBCC. It will be a turnkey project, but the size of the deal, among other details, is yet to be worked out. Both projects are part of the Railways’ plans to modernize as many as 400 stations.
NIIT Technologies: Shares of the company closed 2.35 per cent up at Rs 556 after it informed the exchanges that the company has been selected as a strategic partner by Ofcom, the UK’s communications regulator. NIIT Technologies will help Ofcom manage its infrastructure and application systems and offer a customer focused service to improve the users’ experience of ICT services. The value of the contract is £23m over a six year period which includes an initial term of 4 years and extensions.
Torrent Pharma: Stocks of the pharma company closed 1.13 per cent up at Rs 1430.75 after it launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name ‘Adfrar’.
